BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mroczek A, Zawitkowska J, Kowalczyk J, Lejman M. Comprehensive Overview of Gene Rearrangements in Childhood T-Cell Acute Lymphoblastic Leukaemia. Int J Mol Sci 2021;22:E808. [PMID: 33467425 DOI: 10.3390/ijms22020808] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Lo Nigro L, Andriano N, Buldini B, Silvestri D, Villa T, Locatelli F, Parasole R, Barisone E, Testi AM, Biondi A, Valsecchi MG, Rizzari C, Conter V, Basso G, Cazzaniga G. FLT3-ITD in Children with Early T-cell Precursor (ETP) Acute Lymphoblastic Leukemia: Incidence and Potential Target for Monitoring Minimal Residual Disease (MRD). Cancers (Basel) 2022;14:2475. [PMID: 35626079 DOI: 10.3390/cancers14102475] [Reference Citation Analysis]
2 Grunenberg A, Sala E, Kapp-Schwoerer S, Viardot A. Pharmacotherapeutic management of T-cell acute lymphoblastic leukemia in adults: an update of the literature. Expert Opin Pharmacother 2022;:1-11. [PMID: 35193450 DOI: 10.1080/14656566.2022.2033725] [Reference Citation Analysis]
3 Liu S, Wang H, Guo W, Zhou X, Shu Y, Liu H, Yang L, Tang S, Su H, Liu Z, Zeng L, Zou L. MiR-652-5p elevated glycolysis level by targeting TIGAR in T-cell acute lymphoblastic leukemia. Cell Death Dis 2022;13:148. [PMID: 35165280 DOI: 10.1038/s41419-022-04600-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Kalhori MR, Soleimani M, Arefian E, Alizadeh AM, Mansouri K, Echeverria J. The potential role of miR-1290 in cancer progression, diagnosis, prognosis, and treatment: An oncomiR or onco-suppressor microRNA? J Cell Biochem 2021. [PMID: 34897783 DOI: 10.1002/jcb.30191] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
5 Lato MW, Przysucha A, Grosman S, Zawitkowska J, Lejman M. The New Therapeutic Strategies in Pediatric T-Cell Acute Lymphoblastic Leukemia. Int J Mol Sci 2021;22:4502. [PMID: 33925883 DOI: 10.3390/ijms22094502] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]